<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 21)*
Abbott Laboratories
------------------------------------------------------------
(Name of Issuer)
Common Stock without par value
------------------------------------------------------------
(Title of Class of Securities)
002824 10 0
----------------------------------------
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on following page(s))
Page 1 of 12 Pages
<PAGE>
- ------------------------ ---------------------
CUSIP No. 002824 10 0 13G Page 2 of 12 Pages
- ------------------------ ---------------------
- ------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Abbott Laboratories Stock Retirement Trust
I.R.S. Identification No. 36-6047554
- ------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) /X/
- ------------------------------------------------------------------------------
3 SEC USE ONLY
- ------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Illinois
----------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF 0
----------------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 102,256,673
----------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
----------------------------------------------------------
WITH 8 SHARED DISPOSITIVE POWER
102,256,673
- ------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
102,256,673
- ------------------------------------------------------------------------------
10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- ------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.6%
- ------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
EP
- ------------------------------------------------------------------------------
*SEE INSTRUCTIONS
<PAGE>
- ------------------------ ---------------------
CUSIP No. 002824 10 0 13G Page 3 of 12 Pages
- ------------------------ ---------------------
- ------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Gary P. Coughlan
###-##-####
- ------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) /X/
- ------------------------------------------------------------------------------
3 SEC USE ONLY
- ------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- ------------------------------------------------------------------------------
5 SOLE VOTING POWER
230,620 shares - (Does not include shares held in
NUMBER OF direct the Abbott Laboratories Stock
Retirement Trust for the benefit
of the reporting person.)
----------------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 105,321,505 - See Attached Exhibit 1
----------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING 230,620 shares (see note in 5 above)
PERSON direct
----------------------------------------------------------
WITH 8 SHARED DISPOSITIVE POWER
105,321,505 - as Co-Trustee, Abbott
Laboratories Stock Retirement
Trust.
- ------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
105,977,734 - (Total of 5 + 6 + 425,609 shares - right to acquire
by exercise of stock options.)
- ------------------------------------------------------------------------------
10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- ------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.8%
- ------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- ------------------------------------------------------------------------------
*SEE INSTRUCTIONS
<PAGE>
- ------------------------ ---------------------
CUSIP No. 002824 10 0 13G Page 4 of 12 Pages
- ------------------------ ---------------------
- ------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Greg W. Linder
###-##-####
- ------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) /X/
- ------------------------------------------------------------------------------
3 SEC USE ONLY
- ------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- ------------------------------------------------------------------------------
5 SOLE VOTING POWER
14,272 shares - (Does not include shares held in
NUMBER OF direct the Abbott Laboratories Stock
Retirement Trust for the benefit
of the reporting person.)
----------------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 105,321,505 - See Attached Exhibit 1
----------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING direct 14,272 shares (see note in 5 above)
PERSON
----------------------------------------------------------
WITH 8 SHARED DISPOSITIVE POWER
105,321,505 - as Co-Trustee, Abbott Laboratories
Stock Retirement Trust.
- ------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
105,397,147 - (Total of 5 + 6 + 61,370 shares - right to acquire by
exercise of stock options.)
- ------------------------------------------------------------------------------
10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- ------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.8%
- ------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- ------------------------------------------------------------------------------
*SEE INSTRUCTIONS
<PAGE>
- ------------------------ ---------------------
CUSIP No. 002824 10 0 13G Page 5 of 12 Pages
- ------------------------ ---------------------
- ------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Thomas M. Wascoe
###-##-####
- ------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) /X/
- ------------------------------------------------------------------------------
3 SEC USE ONLY
- ------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- ------------------------------------------------------------------------------
5 SOLE VOTING POWER
20,000 shares - (Does not include shares held in
NUMBER OF direct the Abbot Laboratories Stock
Retirement Trust for the benefit
of the reporting person.)
----------------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 105,321,505 - See Attached Exhibit 1
----------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING 20,000 shares (see note in 5 above)
PERSON direct
----------------------------------------------------------
WITH 8 SHARED DISPOSITIVE POWER
105,321,505 - as Co-Trustee, Abbott Laboratories
Stock Retirement Trust.
- ------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
105,392,239 - (Total of 5 + 6 + 50,734 shares - right to acquire by
exercise of stock options.)
- ------------------------------------------------------------------------------
10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- ------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.8%
- ------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- ------------------------------------------------------------------------------
*SEE INSTRUCTIONS
<PAGE>
Item 1(a) Name of Issuer:
Abbott Laboratories
Item 1(b) Address of Issuer's Principal Executive Offices:
100 Abbott Park Road
Abbott Park, Illinois 60064-6400
Item 2(a) Name of Persons Filing:
Abbott Laboratories Stock Retirement Trust
Gary P. Coughlan
Greg W. Linder
Thomas M. Wascoe
Item 2(b) Address of Principal Business Office:
100 Abbott Park Road
Abbott Park, Illinois 60064-6400
Item 2(c) Citizenship:
Abbott Laboratories Stock Retirement Trust - Illinois.
Gary P. Coughlan, Greg W. Linder, and
Thomas M. Wascoe - United States
Item 2(d) Title of Class of Securities:
Common shares without par value
Item 2(e) CUSIP Number:
002824 10 0
Item 3. If this statement is filed pursuant to Section 240.13d-1(b)
or 240.13d-2(b) or (c), check whether the person filing is
an:
[X] An employee benefit plan or endowment fund in
accordance with Rule 13d-1 (b)(1)(ii)(F).
Page 6 of 12 pages
<PAGE>
Item 4. Ownership
(a) (See cover pages 2, 3,
(b) 4 and 5, Items 5 through
(c) 9 and 11.)
Item 5. Ownership of Five Percent or Less of a Class
Not applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
The shares owned by the Abbott Laboratories Stock Retirement
Trust and the dividends thereon are held for the benefit of
participants of the Abbott Laboratories Stock Retirement Plan
pursuant to terms of that Plan and the Trust. The Abbott
Laboratories Stock Retirement Plan is a qualified profit sharing
plan. As of December 31, 1999, there were 36,577 participants
with share balances in the Plan.
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent Holding
Company or Control Person.
Not applicable.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of Dissolution of Group.
Not applicable.
Item 10. Certification.
Not applicable.
Signature
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
This statement is filed on behalf of each individual listed below pursuant to
their agreement.
Date: February 9, 2000 ABBOTT LABORATORIES STOCK
RETIREMENT TRUST
/s/ Gary P. Coughlan
------------------------------
Gary P. Coughlan, Co-Trustee
/s/ Greg W. Linder
------------------------------
Greg W. Linder, Co-Trustee
/s/ Thomas M. Wascoe
------------------------------
Thomas M. Wascoe, Co-Trustee
Page 7 of 12 pages
<PAGE>
EXHIBIT 1
Schedule 13G
Amendment No. 21
Abbott Laboratories
Common shares without par value
CUSIP Number 002824 10 0
Messrs. Coughlan, Linder, and Wascoe are Co-trustees of the Abbott
Laboratories Stock Retirement Trust, committee members of a committee
established under the Abbott Laboratories Stock Retirement Trust (Puerto
Rico), Trustees of the Abbott Laboratories Employee Benefit Trust, and
members of the Abbott Stock Committee for the Abbott Laboratories Ashland
Union 401(k) Trust. As such, each of them has shared voting power over the
105,321,505 shares held by those trusts. This total is comprised of the
following components:
<TABLE>
<CAPTION>
Number of Shares Name of Trust
---------------- -------------
<S> <C>
102,256,673 Abbott Laboratories Stock Retirement Trust
2,978,507 Abbott Laboratories Stock Retirement Trust
(Puerto Rico)
52,000 Abbott Laboratories Employee Benefit Trust
34,325 Abbott Laboratories Ashland Union 401(k)
Trust
</TABLE>
Page 8 of 12 Pages
<PAGE>
Disclaimer of Beneficial Ownership
under Rule 13d-4
----------------------------------
The filing of Schedule 13G Amendment 21 on behalf of the Abbott Laboratories
Stock Retirement Trust does not constitute an admission that the undersigned
is, for purposes of Section 13(d) of the Securities and Exchange Act of 1934,
the beneficial owner of any securities covered by the Schedule. Pursuant to
Rule 13d-4 of the Act, the undersigned disclaims such ownership with respect
to any shares listed therein of which he would not otherwise be deemed to be
beneficial owner.
/s/ Gary P. Coughlan
----------------------------------
Gary P. Coughlan
Date: February 9, 2000
Page 9 of 12 Pages
<PAGE>
Disclaimer of Beneficial Ownership
under Rule 13d-4
----------------------------------
The filing of Schedule 13G Amendment 21 on behalf of the Abbott Laboratories
Stock Retirement Trust does not constitute an admission that the undersigned
is, for purposes of Section 13(d) of the Securities and Exchange Act of 1934,
the beneficial owner of any securities covered by the Schedule. Pursuant to
Rule 13d-4 of the Act, the undersigned disclaims such ownership with respect
to any shares listed therein of which he would not otherwise be deemed to be
beneficial owner.
/s/ Greg W. Linder
----------------------------------
Greg W. Linder
Date: February 9, 2000
Page 10 of 12 Pages
<PAGE>
Disclaimer of Beneficial Ownership
under Rule 13d-4
----------------------------------
The filing of Schedule 13G Amendment 21 on behalf of the Abbott Laboratories
Stock Retirement Trust does not constitute an admission that the undersigned
is, for purposes of Section 13(d) of the Securities and Exchange Act of 1934,
the beneficial owner of any securities covered by the Schedule. Pursuant to
Rule 13d-4 of the Act, the undersigned disclaims such ownership with respect
to any shares listed therein of which she would not otherwise be deemed to be
beneficial owner.
/s/ Thomas M. Wascoe
----------------------------------
Thomas M. Wascoe
Date: February 9, 2000
Page 11 of 12 Pages
<PAGE>
EXHIBIT 2
AGREEMENT
ABBOTT LABORATORIES STOCK RETIREMENT TRUST
SECURITIES AND EXCHANGE COMMISSION SCHEDULE 13G FILINGS
The undersigned, being co-trustees of the Abbott Laboratories Stock
Retirement Trust (the "Trust"), hereby agree that one Securities and Exchange
Commission Schedule 13G (and any required amendment(s) thereto) be filed on
their behalf with respect to the Trust's beneficial ownership interest in
shares of common stock of Abbott Laboratories. This Agreement may be revoked
in writing by any one of the undersigned.
/s/ Gary P. Coughlan
Date: February 9, 2000 ----------------------------------
Gary P. Coughlan
/s/ Greg W. Linder
----------------------------------
Greg W. Linder
/s/ Thomas M. Wascoe
----------------------------------
Thomas M. Wascoe
Page 12 of 12 Pages
